Slagelse Hospital
- Address
- lock Available on a paid plan
Cardiovascular Research
At Slagelse Hospital, a major share of the clinical trial portfolio focuses on cardiovascular diseases, including heart failure, atrial fibrillation, myocardial infarction, and broader atherosclerotic cardiovascular disease. These studies are designed to test new treatments, lower the risk of serious heart and vascular events, and improve long-term outcomes for people with high cardiovascular risk.
- Testing therapies to prevent stroke, heart attack, and other major cardiovascular events
- Evaluating treatments for chronic and acute heart failure
- Studying risk reduction in patients with established or high-risk cardiovascular disease
Research in this area also includes strategies for managing hypertension and improving care for patients with elevated lipoprotein(a) or other cardiovascular risk factors.
Emergency and Critical Care
The site conducts important trials in acute care, intensive care, and anesthesia and analgesia, with a strong focus on urgent conditions such as sepsis, septic shock, and in-hospital cardiac arrest. The aim is to improve survival, support recovery, and identify better treatment approaches for critically ill patients.
- Assessing treatments for sepsis and severe infection in critically ill adults
- Evaluating emergency interventions during cardiac arrest and acute heart failure
- Comparing care strategies used in intensive care and hospital emergency settings
These studies reflect a practical focus on improving outcomes in time-sensitive situations where treatment decisions must be made quickly.
Digestive System and Surgical Care
Clinical research at Department of Surgery in Slagelse Hospital also covers digestive system diseases and perioperative care, including major emergency abdominal surgery and peritonitis. The trials are aimed at improving infection control, nutritional support, and recovery after surgery.
- Studying ways to reduce infections after emergency abdominal surgery
- Testing treatments for complex abdominal infections such as peritonitis
- Exploring supportive care approaches that may improve postoperative recovery
This area of research is especially relevant for patients facing urgent surgical treatment and complicated abdominal illness.
Oncology and Cancer Supportive Care
The site is involved in neoplasm research, especially colorectal cancer and localized colon cancer. These trials look at ways to strengthen cancer treatment, improve immune response, and support physical recovery during and after therapy.
- Evaluating new approaches to improve treatment response in colorectal cancer
- Studying supportive therapies that may help physical capacity and recovery
- Investigating immune-related changes linked to cancer care
Research in this area combines cancer treatment with broader supportive care goals, including better quality of life and improved patient resilience.
Neurology, Musculoskeletal, and Metabolic Conditions
Several trials at the site address nervous system diseases, musculoskeletal diseases, and nutritional and metabolic diseases, including multiple sclerosis, psoriatic arthritis, axial spondyloarthritis, fracture care, and type 1 diabetes. The research is focused on testing better disease control, easing symptoms, and supporting function in everyday life.
- Studying therapies for relapsing multiple sclerosis
- Assessing treatment effects in inflammatory joint and spine disease
- Exploring ways to preserve beta cell function in early type 1 diabetes
These studies show a broad interest in chronic inflammatory and metabolic conditions, alongside practical care for acute injuries.
Quality of Care and Diagnostic Support
Some of the research at Slagelse Hospital also addresses health care quality and clinical decision-making, with a focus on improving treatment choices and patient outcomes across different specialties. This includes studies that compare established care options and evaluate how well they work in real-world hospital settings.
- Comparing standard treatments to identify the most effective care strategies
- Supporting better clinical decisions in urgent and chronic disease management
- Improving the overall quality and effectiveness of hospital-based care
Across its trial portfolio, the site contributes to research that is both clinically practical and directly relevant to patient care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 12 therapeutic areas and 15 of 105 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 98 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 12 by active trials.
- 1Zealand University Hospital4active
lock +11 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Zealand University Hospital5trials
lock +9 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Slagelse Hospital
lock Showing 1 of 31 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk | Merck Sharp & Dohme LLC | Phase III | Not Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 105 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sodium Chloride | 4 | Unknown | 2023-02-06 | 2024-10-10 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.